JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Functional Imaging of Tumor and Normal Tissue

Terminated

Conditions: Head and Neck Cancer

Interventions: Procedure: MRI and PET imaging

First Posted Date: 2009-07-07

Last Posted Date: 2012-04-11

Lead Sponsor: Duke University

Target Recruit Count: 21

Registration Number: NCT00933114

Locations: 🇺🇸
Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, United States

Tailored Intervention Protocol for Oral Chemotherapy Adherence

Not Applicable

Completed

Conditions: Cancer

Interventions: Behavioral: Nurse Coaching

First Posted Date: 2009-07-03

Last Posted Date: 2014-07-15

Lead Sponsor: Duke University

Target Recruit Count: 48

Registration Number: NCT00932490

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Continuous Cardiac Arrhythmia Monitoring in Hemodialysis Patients

Completed

Conditions: Arrhythmias, Cardiac

Interventions: Device: continuous cardiac monitoring device (REVEAL, Medtronic)

First Posted Date: 2009-07-03

Last Posted Date: 2013-04-19

Lead Sponsor: Duke University

Target Recruit Count: 8

Registration Number: NCT00932659

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Atkins Diet and Prostate Cancer Clinical Trial

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Behavioral: Atkins Diet

First Posted Date: 2009-07-03

Last Posted Date: 2015-12-07

Lead Sponsor: Duke University

Target Recruit Count: 45

Registration Number: NCT00932672

Locations: 🇺🇸
Greater Los Angeles VA Medical Center, Los Angeles, California, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Phase 1

Completed

Conditions: Non Small Cell Lung Cancer
Small Cell Lung Cancer
Thymoma
Thymus Neoplasms

Interventions: Radiation: Esophageal sparing IMRT

First Posted Date: 2009-06-16

Last Posted Date: 2020-04-02

Lead Sponsor: Duke University

Target Recruit Count: 24

Registration Number: NCT00921739

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Nilutamide
Drug: Dasatinib

First Posted Date: 2009-06-11

Last Posted Date: 2014-10-29

Lead Sponsor: Duke University

Target Recruit Count: 57

Registration Number: NCT00918385

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸
University of Washington/Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Preventing Postpartum Return to Smoking

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: Tailored Counseling Intervention Arm

First Posted Date: 2009-06-11

Last Posted Date: 2013-04-10

Lead Sponsor: Duke University

Target Recruit Count: 386

Registration Number: NCT00917943

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use

Completed

Conditions: Sudden Cardiac Arrest

First Posted Date: 2009-06-11

Last Posted Date: 2015-10-19

Lead Sponsor: Duke University

Target Recruit Count: 59

Registration Number: NCT00918125

Locations: 🇺🇸
Alamance Regional Medical Center, Burlington, North Carolina, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

Phase 2

Completed

Conditions: Malignant Glioma

Interventions: Drug: Palonosetron (PALO)

First Posted Date: 2009-05-13

Last Posted Date: 2019-08-28

Lead Sponsor: Duke University

Target Recruit Count: 57

Registration Number: NCT00900757

Locations: 🇺🇸
The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant

Phase 2

Completed

Conditions: Multiple Myeloma
Non-Hodgkins Lymphoma
Hodgkins Disease

Interventions: Drug: G-CSF plus Plerixafor

First Posted Date: 2009-05-13

Last Posted Date: 2014-05-07

Lead Sponsor: Duke University

Target Recruit Count: 21

Registration Number: NCT00901225

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy